Fibrosis progression after liver transplantation in patients with recurrent hepatitis C

Journal of Hepatology

Volumn 41, Issue 5, 2004, Pages 830-836

  Neumann, Ulf P ^a,b   Berg, Thomas ^b   Bahra, Marcus ^a   Seehofer, Daniel ^a   Langrehr, Jan M ^a   Neuhaus, Ruth ^a   Radke, Cornelia ^b   Neuhaus, Peter ^a  

^a Experimentelle Morphol Univ K   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Hepatitis C; Histological progression; Liver transplantation; Outcome

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MEPREDNISONE; MONOCLONAL ANTIBODY CD3; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; ORTHOCLONE; STEROID; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EVALUATION; FEMALE; FOLLOW UP; GENOTYPE; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SCORING SYSTEM; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TIME SERIES ANALYSIS; VIRUS GENE;

ADULT; AGED; BIOPSY; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 7244247475     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.06.029     Document Type: Article

References (34)

1. M. Berenguer, and T.L. Wright Hepatitis C and liver transplantation Gut 45 1999 159 163
2. J. Ahmad, S.F. Dodson, A.J. Demetris, J.J. Fung, and A.O. Shakil Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin Liver Transpl 7 2001 863 869
3. R.M. Ghobrial, R. Steadman, J. Gornbein, C. Lassman, C.D. Holt, and P. Chen A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients Ann Surg 234 2001 384 393
4. M. Berenguer, M. Prieto, F. San Juan, J.M. Rayon, F. Martinez, and D. Carrasco Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202 210
5. L.M. Forman, J.D. Lewis, J.A. Berlin, H.I. Feldmann, and M.R. Lucey The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
6. E.J. Gane, B.C. Portmann, N.V. Naoumov, H.M. Smith, J.A. Underhill, and P.T. Donaldson Long-term outcome of hepatitis C infection after liver transplantation [see comments] N Engl J Med 334 1996 815 820
7. G.V. Papatheodoridis, S. Davies, A.P. Dhillon, R. Teixeira, J. Goulis, and B. Davidson The role of different immunosuppression in the long-term histological outcome of HCV reinfection after liver transplantation for HCV cirrhosis Transplantation 72 2001 412 418
8. P.A. Sheiner, L.K. Schluger, S. Emre, S.N. Thung, J.Y. Lau, and S.R. Guy Retransplantation for recurrent hepatitis C Liver Transpl Surg 3 1997 130 136
9. R.M. Ghobrial, D.G. Farmer, A. Baquerizo, S. Colquhoun, H.R. Rosen, and H. Yersiz Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience Ann Surg 229 1999 824 831
10. T. Gayowski, N. Singh, I.R. Marino, H. Vargas, M. Wagener, and C. Wannstedt Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome Transplantation 64 1997 422 426
11. H.R. Rosen, C.R. Shackleton, L. Higa, I.M. Gralnek, D.A. Farmer, and S.V. McDiarmid Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation [see comments] Am J Gastroenterol 92 1997 1453 1457
12. T. Berg, U. Hopf, W.O. Bechstein, A.R. Muller, T. Fukumoto, and R. Neuhaus Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantation Transplantation 66 1998 225 228
13. M. Charlton, E. Seaberg, R. Wiesner, J. Everhart, R. Zetterman, and J. Lake Predictors of patient and graft survival following liver transplantation for hepatitis C Hepatology 28 1998 823 830
14. M. Wali, R.F. Harrison, P.J. Gow, and D. Mutimer Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C Gut 51 2002 248 252
15. M.L. Shiffman, M.J. Contos, V.A. Luketic, A.J. Sanyal, P.P. Purdum 3rd, and A.S. Mills Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation Transplantation 57 1994 526 532
16. V.J. Desmet, M. Gerber, J.H. Hoofnagle, M. Manns, and P.J. Scheuer Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1520
17. P. Neuhaus, W.O. Bechstein, G. Blumhardt, M. Wiens, P. Lemmens, and J.M. Langrehr Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody Transplantation 55 1993 1320 1327
18. P. Neuhaus, G. Blumhardt, W.O. Bechstein, R. Steffen, K.P. Platz, and H. Keck Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants Ann Surg 219 1994 426 434
19. P. Neuhaus, J.M. Langrehr, R. Williams, R.Y. Calne, R. Pichlmayr, and P. McMaster Tacrolimus-based immunosuppression after liver transplantation: a randomised study comparing dual versus triple low-dose oral regimens Transpl Int 10 1997 253 261
20. J.M. Langrehr, N.C. Nussler, U. Neumann, O. Guckelberger, R. Lohmann, and A. Radtke A prospective randomized trial comparing interleukin-2 receptor antibody versus antithymocyte globulin as part of a quadruple immunosuppressive induction therapy following orthotopic liver transplantation Transplantation 63 1997 1772 1781
21. N. Rayes, D. Seehofer, C.A. Schmidt, H. Oettle, A.R. Muller, and T. Steinmuller Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation Transplantation 72 2001 881 885
22. M. Sebagh, K. Rifai, C. Feray, F. Yilmaz, B. Falissard, and B. Roche All liver recipients benefit from the protocol 10-year liver biopsies Hepatology 37 2003 1293 1301
23. C. Feray, L. Caccamo, G.J. Alexander, B. Ducot, J. Gugenheim, and T. Casanovas European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group Gastroenterology 117 1999 619 625
24. M. Berenguer, F.X. Lopez Labrador, and T.L. Wright Hepatitis C and liver transplantation J Hepatol 35 2001 666 678
25. S. Zhou, N.A. Terrault, L. Ferrell, J.A. Hahn, J.Y. Lau, and P. Simmonds Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia Hepatology 24 1996 1041 1046
26. T. Wong, J. Devlin, N. Rolando, N. Heaton, and R. Williams Clinical characteristics affecting the outcome of liver retransplantation Transplantation 64 1997 878 882
27. E.J. Gane, N.V. Naoumov, K.P. Qian, M.U. Mondelli, G. Maertens, and B.C. Portmann A longitudinal analysis of hepatitis C virus replication following liver transplantation Gastroenterology 110 1996 167 177
28. U.P. Neumann, T. Berg, M. Bahra, G. Puhl, O. Guckelberger, J.M. Langrehr, and P. Neuhaus Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up Transplantation 77 2004 226 231
29. T. Poynard, P. Bedossa, and P. Opolon Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups Lancet 349 1997 825 832
30. M. Berenguer, L. Ferrell, J. Watson, M. Prieto, M. Kim, and M. Rayon HCV-related fibrosis progression following liver transplantation: increase in recent years J Hepatol 32 2000 673 684
31. M. Berenguer, J.M. Rayon, M. Prieto, V. Aguilera, D. Nicolas, and V. Ortiz Are posttransplantation protocol liver biopsies useful in the long term? Liver Transpl 7 2001 790 796
32. M. Guido, S. Fagiuoli, G. Tessari, P. Burra, G. Leandro, and P. Boccagni Histology predicts cirrhotic evolution of post transplant hepatitis C Gut 50 2002 697 700
33. D.V. Gopal, J.M. Rabkin, B.S. Berk, C.L. Corless, S. Chou, and A. Olyaei Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavarin Liver Transpl 3 2001 181 190
34. S. Zeuzem, S.V. Feinmann, J. Rasenack, E.J. Heathcote, M.Y. Lai, and E. Gane Peginterferon alfa-2a in patients with chronic hepatitis C N Engl J Med 343 2000 1666 1672